{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T17:45:52Z","timestamp":1784223952554,"version":"3.55.0"},"reference-count":33,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Otolaryngology"],"published-print":{"date-parts":[[2022,5]]},"DOI":"10.1016\/j.amjoto.2022.103465","type":"journal-article","created":{"date-parts":[[2022,4,8]],"date-time":"2022-04-08T09:28:27Z","timestamp":1649410107000},"page":"103465","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Adjunctive use of saturated solution of potassium iodide (SSKI) with liposomal amphotericin B (L-AMB) in mucormycosis achieves favorable response, shortened dose and duration of amphotericin: A retrospective study from a COVID-19 tertiary care center"],"prefix":"10.1016","volume":"43","author":[{"given":"Sumit","family":"Mrig","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kabir","family":"Sardana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pooja","family":"Arora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vineet","family":"Narula","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandeep","family":"Arora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amrit","family":"Kapoor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ritu Raj","family":"Baruah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Poornima","family":"Sen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shweta","family":"Agarwal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soumya","family":"Sachdeva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arun","family":"Dewan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjeet","family":"Panesar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.amjoto.2022.103465_bb0005","doi-asserted-by":"crossref","DOI":"10.1016\/S2666-5247(20)30127-0","article-title":"COVID-19 and fungal infection: the need for a strategic approach","volume":"1","author":"White","year":"2020","journal-title":"Lancet Microbe"},{"key":"10.1016\/j.amjoto.2022.103465_bb0010","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1007\/s15010-021-01670-1","article-title":"COVID-19 and mucormycosis superinfection: the perfect storm","volume":"49","author":"Al-Tawfiq","year":"2021","journal-title":"Infection"},{"key":"10.1016\/j.amjoto.2022.103465_bb0015","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.4103\/ijo.IJO_1165_21","article-title":"Code mucor: guidelines for the diagnosis, staging and Management of Rhino-Orbito-Cerebral Mucormycosis in the setting of COVID-19","volume":"69","author":"Honavar","year":"2021","journal-title":"Indian J Ophthalmol"},{"key":"10.1016\/j.amjoto.2022.103465_bb0020","article-title":"Repurposing super saturated potassium iodide as an adjunctive treatment in mucormycosis: an exposition in a diabetic patient with rhino-orbital disease with cutaneous extension","volume":"27","author":"Sardana","year":"2021","journal-title":"Dermatol Ther"},{"key":"10.1016\/j.amjoto.2022.103465_bb0025","first-page":"239","article-title":"Orbital mucormycosis (phycomycosis) (a survival with amphotericin-B and potassium iodide)","volume":"33","author":"Grewal","year":"1985","journal-title":"Indian J Ophthalmol"},{"key":"10.1016\/j.amjoto.2022.103465_bb0030","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1111\/myc.12958","article-title":"Mucormycosis in South America: a review of 143 reported cases","volume":"62","author":"Nucci","year":"2019","journal-title":"Mycoses"},{"key":"10.1016\/j.amjoto.2022.103465_bb0035","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1172\/JCI42164","article-title":"The endothelial cell receptor GRP78 is required for mucormycosis pathogenesis in diabetic mice","volume":"120","author":"Liu","year":"2010","journal-title":"J Clin Invest"},{"key":"10.1016\/j.amjoto.2022.103465_bb0040","doi-asserted-by":"crossref","first-page":"944.e9","DOI":"10.1016\/j.cmi.2019.11.021","article-title":"A multicentre observational study on the epidemiology, risk factors, management and outcomes of mucormycosis in India","volume":"26","author":"Patel","year":"2020","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.amjoto.2022.103465_bb0045","doi-asserted-by":"crossref","first-page":"265","DOI":"10.3390\/jof6040265","article-title":"Epidemiology and diagnosis of mucormycosis: an update","volume":"6","author":"Skiada","year":"2020","journal-title":"J Fungi (Basel)"},{"key":"10.1016\/j.amjoto.2022.103465_bb0050","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/s00592-009-0109-4","article-title":"Binding of SARS coronavirus to its receptor damages islets and causes acute diabetes","volume":"47","author":"Yang","year":"2010","journal-title":"Acta Diabetol"},{"key":"10.1016\/j.amjoto.2022.103465_bb0055","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1086\/313803","article-title":"Zygomycosis in the 1990s in a tertiary-care cancer center","volume":"30","author":"Kontoyiannis","year":"2000","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.amjoto.2022.103465_bb0060","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1016\/S0140-6736(03)14904-5","article-title":"Glucocorticoids and invasive fungal infections","volume":"29","author":"Lionakis","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.amjoto.2022.103465_bb0065","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/s12026-020-09145-5","article-title":"COVID-19 as part of the hyperferritinemic syndromes: the role of iron depletion therapy","volume":"68","author":"Perricone","year":"2020","journal-title":"Immunol Res"},{"issue":"Suppl 1","key":"10.1016\/j.amjoto.2022.103465_bb0070","doi-asserted-by":"crossref","first-page":"S16","DOI":"10.1093\/cid\/cir865","article-title":"Pathogenesis of mucormycosis","volume":"54","author":"Ibrahim","year":"2012","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.amjoto.2022.103465_bb0075","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1172\/JCI116419","article-title":"Mucormycosis during deferoxamine therapy is a siderophore-mediated infection: in vitro and in vivo animal studies","volume":"91","author":"Boelaert","year":"1993","journal-title":"J Clin Invest"},{"issue":"Suppl 1","key":"10.1016\/j.amjoto.2022.103465_bb0080","article-title":"Pathogenesis of mucormycosis","volume":"54","author":"Ibrahim","year":"2012","journal-title":"Clin Infect Dis"},{"issue":"54 Suppl 1","key":"10.1016\/j.amjoto.2022.103465_bb0085","doi-asserted-by":"crossref","first-page":"S44","DOI":"10.1093\/cid\/cir867","article-title":"Healthcare-associated mucormycosis","volume":"2012","author":"Rammaert","year":"2012","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.amjoto.2022.103465_bb0090","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/microorganisms9030523","article-title":"Epidemiology of mucormycosis in India","volume":"9","author":"Prakash","year":"2021","journal-title":"Microorganisms"},{"key":"10.1016\/j.amjoto.2022.103465_bb0095","doi-asserted-by":"crossref","unstructured":"RE Lewis ND Albert G Liao J Hou RA Prince DP. Kontoyiannisn.d.Comparative pharmacodynamics of amphotericin B lipid complex and liposomal amphotericin B in a murine model of pulmonary mucormycosis. Antimicrob Agents Chemother 54:1298-1304.","DOI":"10.1128\/AAC.01222-09"},{"key":"10.1016\/j.amjoto.2022.103465_bb0100","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.02651-16","article-title":"Retrospective cohort analysis of liposomal amphotericin B nephrotoxicity in patients with hematological malignancies","volume":"61","author":"Stanzani","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.amjoto.2022.103465_bb0105","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1046\/j.1365-2141.1997.2473063.x","article-title":"A randomized comparison of liposomal versus conventional amphotericin B for the treatment of pyrexia of unknown origin in neutropenic patients","volume":"98","author":"Prentice","year":"1997","journal-title":"Br J Haematol"},{"key":"10.1016\/j.amjoto.2022.103465_bb0110","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1097\/MD.0b013e3181e9441b","article-title":"Drug-induced nephrotoxicity caused by amphotericin B lipid complex and liposomal amphotericin B: a review and meta-analysis","volume":"89","author":"Safdar","year":"2010","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.amjoto.2022.103465_bb0115","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1086\/514341","article-title":"Liposomal amphotericin B as initial therapy for invasive mold infection: a randomized trial comparing a high-loading dose regimen with standard dosing (AmBiLoad trial)","volume":"44","author":"Cornely","year":"2007","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.amjoto.2022.103465_bb0120","doi-asserted-by":"crossref","first-page":"3116","DOI":"10.1093\/jac\/dkv236","article-title":"French mycosis study group. Prospective pilot study of high-dose (10 mg\/kg\/day) liposomal amphotericin B (L-AMB) for the initial treatment of mucormycosis","volume":"70","author":"Lanternier","year":"2015","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.amjoto.2022.103465_bb0125","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1111\/j.1469-0691.2010.03456.x","article-title":"European Confederation of Medical Mycology Working Group on Zygomycosis. Zygomycosis in Europe: analysis of 230 cases accrued by the registry of the European Confederation of Medical Mycology (ECMM) Working Group on Zygomycosis between 2005 and 2007","volume":"17","author":"Skiada","year":"2011","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.amjoto.2022.103465_bb0130","doi-asserted-by":"crossref","first-page":"e405","DOI":"10.1016\/S1473-3099(19)30312-3","volume":"19","author":"Cornely","year":"2019","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.amjoto.2022.103465_bb0135","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1086\/590004","article-title":"Delaying amphotericin B-based frontline therapy significantly increases mortality among patients with hematologic malignancy who have zygomycosis","volume":"47","author":"Chamilos","year":"2008","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.amjoto.2022.103465_bb0140","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1111\/myc.13335","article-title":"ECMM and ISHAM. ECMM\/ISHAM recommendations for clinical management of COVID-19 associated mucormycosis in low- and middle-income countries","volume":"64","author":"Rudramurthy","year":"2021","journal-title":"Mycoses"},{"issue":"Suppl 3","key":"10.1016\/j.amjoto.2022.103465_bb0145","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1111\/myc.12234","article-title":"Molecular characterization and in vitro antifungal susceptibility of 80 clinical isolates of mucormycetes in DelhiIndia","volume":"57","author":"Chowdhary","year":"2014","journal-title":"Mycoses"},{"key":"10.1016\/j.amjoto.2022.103465_bb0150","doi-asserted-by":"crossref","first-page":"475","DOI":"10.4103\/idoj.IDOJ_3_17","article-title":"Lymphocutaneous sporotrichosis treated with potassium iodide with development of subclinical hypothyroidism: wolff-chaikoff Effect?","volume":"8","author":"Arora","year":"2017","journal-title":"Indian Dermatol Online J"},{"key":"10.1016\/j.amjoto.2022.103465_bb0155","doi-asserted-by":"crossref","first-page":"616","DOI":"10.4103\/0378-6323.168332","article-title":"Entomophthoromycosis (basidiobolomycosis) presenting with \"saxophone\" penis and responding to potassium iodide","volume":"81","author":"Arora","year":"2015","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"10.1016\/j.amjoto.2022.103465_bb0160","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1111\/j.1439-0507.1989.tb02279.x","article-title":"Effect of immunization and potassium iodide on polymorphonuclear leukocyte chemiluminescence in experimental murine sporotrichosis","volume":"32","author":"Shimizu","year":"1989","journal-title":"Mycoses"},{"key":"10.1016\/j.amjoto.2022.103465_bb0165","doi-asserted-by":"crossref","DOI":"10.1111\/dth.12610","article-title":"Exploring the combination of SSKI and topical heparin in a case of erythema nodosum migrans","volume":"31","author":"Sehrawat","year":"2018","journal-title":"Dermatol Ther"}],"container-title":["American Journal of Otolaryngology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0196070922000928?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0196070922000928?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T05:08:36Z","timestamp":1759295316000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0196070922000928"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5]]},"references-count":33,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,5]]}},"alternative-id":["S0196070922000928"],"URL":"https:\/\/doi.org\/10.1016\/j.amjoto.2022.103465","relation":{},"ISSN":["0196-0709"],"issn-type":[{"value":"0196-0709","type":"print"}],"subject":[],"published":{"date-parts":[[2022,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Adjunctive use of saturated solution of potassium iodide (SSKI) with liposomal amphotericin B (L-AMB) in mucormycosis achieves favorable response, shortened dose and duration of amphotericin: A retrospective study from a COVID-19 tertiary care center","name":"articletitle","label":"Article Title"},{"value":"American Journal of Otolaryngology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amjoto.2022.103465","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"103465"}}